Vitamin D and muscle mass and function: potential therapeutic implications

N. Hopkinson (London, United Kingdom)

Source: Annual Congress 2013 –New insights into the mechanisms of muscle dysfunction in COPD
Session: New insights into the mechanisms of muscle dysfunction in COPD
Session type: Symposium
Number: 3012
Disease area: Airway diseases

Slide presentationMultimedia files

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Hopkinson (London, United Kingdom). Vitamin D and muscle mass and function: potential therapeutic implications. Annual Congress 2013 –New insights into the mechanisms of muscle dysfunction in COPD

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Vitamin D and nutritional status in candidates for lung transplantation
Source: Eur Respir J 2002; 20: Suppl. 38, 263s
Year: 2002

The importance of antioxidant vitamin and lung function
Source: Eur Respir J 2005; 26: Suppl. 49, 311s
Year: 2005

Role of vitamin D supplementation in lung function testing and exercise capacity
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016

Vitamin D binding protein: a new biomarker of disease severity in lymphangioleiomyomatosis
Source: Eur Respir J, 52 (5) 1801886; 10.1183/13993003.01886-2018
Year: 2018



Does relationship exist between severity of vitamin D deficiency and development of active TB?
Source: Annual Congress 2012 - Tuberculosis: clinical findings I
Year: 2012


Vitamin D deficiency in lung transplant patients: Is it important?
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011


The association of vitamine D deficiency and skeletal muscle dysfunction in COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015

Vitamin D status and its relationships with bone density in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 43s
Year: 2006

Prognostic and functional significance of osteoporosis and vitamin D deficiency in interstitial lung diseases
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018


Does vitamin D deficiency & bone fragility affect pulmonary function in cystic fibrosis?
Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health
Year: 2008

Vitamin D and skeletal muscle strength and endurance in COPD
Source: Eur Respir J 2013; 41: 309-316
Year: 2013



Oral presentation: Vitamin D binding protein is functionally important in airway infections
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010

The role of vitamin D in asthmatic disease
Source: Breathe 2010; 7: 194-195
Year: 2010

The role of vitamin D in severe asthma
Source: International Congress 2017 – Novel mechanisms in asthma
Year: 2017

Vitamin D levels in patients with active TB: Is it clinically relevant?
Source: International Congress 2018 – Challenges in tuberculosis care
Year: 2018

Vitamin D deficiency and FEV1 decline in COPD
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009


The relationship of vitamin D binding protein polymorphisms with blood vitamin D Level in Korean patients with COPD
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015

Vitamin D deficiency is associated with rapid decline in exercise capacity in male patients with COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016

The relationship between vitamin D deficiency and the main characteristics of COPD patients
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020


The effects of endogenous and exogenous vitamin D on the rate of mature elastin degradation in COPD patients
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016